SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-027573
Filing Date
2021-11-09
Accepted
2021-11-09 08:00:42
Documents
13
Period of Report
2021-11-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38422
  Complete submission text file 0001493152-21-027573.txt   259180

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE harrowinccom-20211105.xsd EX-101.SCH 3796
3 XBRL DEFINITION FILE harrowinccom-20211105_def.xml EX-101.DEF 27125
4 XBRL LABEL FILE harrowinccom-20211105_lab.xml EX-101.LAB 37394
5 XBRL PRESENTATION FILE harrowinccom-20211105_pre.xml EX-101.PRE 25740
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5599
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 211389947
SIC: 2834 Pharmaceutical Preparations